Estimating The Costs And Cost-effectiveness Of Promoting Mammography Screening Among US-based Latinas by Molina, Yamilé et al.
135  Estimating the Costs and Cost-effectiveness of Promoting Mammography Screening among 
US-based Latinas 
Molina, et al. 
 
Journal of Health Disparities Research and Practice Volume 12, Issue 6, Winter 2019 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
Journal of Health Disparities Research and Practice 
Volume 12, Issue 6, Winter 2019, pp. 135-145 
© 2011 Center for Health Disparities Research 
School of Community Health Sciences 
University of Nevada, Las Vegas 
 
 
Estimating the Costs and Cost-effectiveness of Promoting 
Mammography Screening among US-based Latinas 
 
Yamilé Molina, University of Illinois at Chicago 
Catherine M. Pichardo, University of Illinois at Chicago 
Donald L. Patrick, University of Washington 
Scott D. Ramsey, Fred Hutchinson Cancer Research Center 
Sonia Bishop, Fred Hutchinson Cancer Research Center 
Shirley A.A. Beresford PhD, University of Washington 
Gloria Coronado, Kaiser Permanente Center for Health Research 
Corresponding Author:  Yamilé Molina, ymolin2@uic.edu 
 
ABSTRACT 
Purpose: We characterize the costs and cost-effectiveness of a community health worker 
(CHW)-based intervention to promote screening mammography among US-based non-adherent 
Latinas.  
Methods: The parent study was a randomized controlled trial for 536 Latinas aged 42-74 
years old who had sought care within a safety net health center in Western Washington. 
Participants were block-randomized within clinic to the control arm (usual care) or intervention 
arm (CHW-led motivational interviewing intervention). We used the perspective of the 
organization implementing promotional activities to characterize costs and cost-effectiveness. 
Cost data were categorized as program set-up and maintenance (initial training, booster/annual 
training) program implementation (administrative activities, intervention delivery); and, 
overhead/miscellaneous expenses. Cost-effectiveness was calculated as the incremental cost of 
screening for each additional woman screened between the intervention and control arms.  
Results: The respective costs per participant for standard care and the intervention arm 
were $69.96 and $300.99. There were no study arm differences in 1-year QALYs among women 
who completed a 12-month follow-up survey (intervention= 0.8827, standard care = 0.8841). Most 
costs pertained to program implementation and administrative activities specifically. The 
incremental cost per additional woman screened was $2,595.32.  
Conclusions: Our findings are within the ranges of costs and cost-effectiveness for other 
CHW programs to promote screening mammography among underserved populations. Our strong 
study design and focus on non-adherent women provides important strengths to this body of work, 
especially give implementation and dissemination science efforts regarding CHW-based health 
promotion for health disparity populations. 
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INTRODUCTION 
Breast cancer among Latinas residing in the United States (US) presents a complex picture. 
Despite lower incidence of breast cancer relative to non-Latina Whites (NLW), Latinas are more 
likely to be diagnosed at later stages, be diagnosed at younger ages, have larger tumors, and have 
lower five year survival rates (Hedeen & White, 2001; Jemal et al., 2004; Lantz et al., 2006; Miller, 
Hankey, & Thomas, 2002; Ooi, Martinez, & Li, 2011; Siegel, Naishadham, & Jemal, 2012; Wray 
et al., 2013). There are a number of biological, individual, and systemic factors contributing to 
these disparities: nonetheless, the underutilization of routine screening mammography is an 
important factor (Abraído-Lanza, Chao, & Gammon, 2004; Peek & Han, 2004; Smith, Cokkinides, 
& Brawley, 2012; Swan, Breen, Coates, Rimer, & Lee, 2003). Molina and colleagues (2013) 
identified the use of community health workers (CHW) or promotoras as the most common 
strategy for screening mammography promotion among Latinas. Promotoras specifically address 
psycho-sociocultural barriers to screening, including cancer worry/fatalismo, 
embarrassment/vergüenza, religious beliefs, language barriers and healthy literacy (Austin, 
Ahmad, McNally, & Stewart, 2002; Molina et al., 2014; Schettino, Hernandez-Valero, Moguel, 
Hajek, & Jones, 2006). There is a modest overall effect of such promotora-based programs on 
improving screening mammography among Latinas (Luque et al., 2018).  
While the cost-effectiveness of CHW and other community-based practices has been 
assessed for breast cancer screening (Andersen, Hager, Su, & Urban, 2002; Hurley et al., 1992; 
Stockdale, Keeler, Duan, Derose, & Fox, 2000), less work has addressed Latina populations. 
Existing research has suggested a wide range of intervention costs associated with CHW programs 
(Andersen et al., 2002; Meghea & Williams, 2015; Paskett et al., 2006; Stockdale et al., 2000). 
Research characterizing this specific type of program for Latinos is important, as previous 
literature has suggested the cost-effectiveness of community-based strategies varies depending on 
the type of activities used (e.g., individual counselling versus community-based activities) and on 
the characteristics of the target population (Andersen et al., 2002). Cost-effectiveness analyses 
may elucidate refinement of existing community-based programs and future investment in 
promotoras in breast healthcare promotion. For the current study, we conducted a cost-
effectiveness analysis of a promotora-based intervention that focused on removing psycho-
sociocultural barriers to mammography use among a sample of US-based Latinas who had not 
obtained mammograms in the past two years.  
  
METHODS 
Setting 
Between 2012 and 2014, a randomized controlled trial, ¡Fortaleza Latina! was conducted 
to promote screening mammography among non-adherent Latinas residing in Western Washington 
State (Coronado et al., 2016). Participants were from a clinic-based sample from four participating 
sites of a safety net health center. For recruitment, electronic medical records were used to identify 
potential participants who met the following eligibility criteria: 1) identification as Latina or 
Hispanic; 2) no receipt of a screening mammogram within the past two years, confirmed by 
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electronic medical records; 3) age between 42-74 years; and, 4) receipt of care from one of the 
four clinic sites within the past five years. Once identified, participants were invited, screened, 
consented, and completed a baseline questionnaire during an in-person visit in English or Spanish, 
depending on participants’ preferences. Women were then randomized at the clinic level to receive 
a promotora-based intervention or standard care. If randomized to receive the intervention, women 
interacted with promotoras through a motivational interview during another home visit. If 
randomized to receive standard care, women received information about mammograms through 
routine interactions with staff during clinical visits as part of the local National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) affiliate. Electronic medical record data were 
subsequently abstracted to assess the number of women who had subsequently obtained 
mammograms. All intervention procedures and materials were approved by the Fred Hutchinson 
Cancer Research Center’s Institutional Review Board. More details about the intervention design 
have been published elsewhere (Coronado et al., 2014).  
Data Collection 
Survey data collection. Women completed a baseline survey that included 
sociodemographic characteristics healthcare access and breast cancer screening items; and, a post-
randomization; and, a 12-month follow-up survey that included the Short-Form Health Survey 
(SF-12), a well-validated, common instrument for measuring quality of life (Ware, Kosinski, & 
Keller, 1996). 
Cost-effectiveness analysis. For the cost-effectiveness analysis, we used the perspective of 
the organization implementing the promotion of mammography. Cost data were gathered for three 
types of yearly expenses: program set-up and maintenance (initial training, booster/annual 
retraining); program activities (activities associated with intervention delivery (e.g., 
randomization, delivering intervention); administrative activities (e.g., supervision); and 
overhead/miscellaneous day-to-day costs (travel, cellphone, office furnishings, mailing). For each 
cost, the total amount was calculated as the quantity and per unit cost (i.e., salary per hour, per 
mile, yearly cellphone rate, per square foot, and postage). Weighted averages were used to account 
for varying number of months wherein the intervention took place between 2012 and 2014, which 
would have influenced total costs. For the intervention arm, costs were derived from study tracking 
logs and budget expense reports. For the standard care arm, baseline questionnaires were 
distributed during 2012 to one NBCCEDP coordinator at each of the four participating sites. 
Unfortunately, only one site completed the survey in its entirety; the rest completed 30-50% of 
questions. Given this, only data for the site completing the questionnaire were used to represent 
standard care arm costs. All costs were standardized to US dollars in 2019. The primary outcome 
of interest was the number of women who obtained mammograms across study arms and was 
based on electronic medical record data from the larger trial.  
Data Analysis 
To assess the cost-effectiveness of the intervention arm relative to standard care, all 
relevant costs described above were combined with electronic medical record data concerning 
receipt of mammography screening. The formula for the calculation was (CI – CE/EI – EE), wherein: 
 CI  = total costs in the intervention arm; 
 Cc = total costs in the standard care arm; 
EI = number of women obtaining screening mammograms in the intervention arm; and, 
Ec = number of women obtaining screening mammograms in the standard care arm. 
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 In addition, we also estimated the quality adjusted life years (QALY) gained for each 
participant by converting their SF-12 scores to an EQ-5D VAS utility score (Sullivan & 
Ghushcyan, 2006). We used a 1-year horizon, given the study period. The mapping algorithm 
calculates utility scores from the SF-12 Physical Component Summary (PCS) and Mental 
Component Summary (MCS), which cover eight health domains. Any estimated EQ-5D scores >1 
were truncated at 1 to remain within the bounds of the EQ-5D instrument. The formula was: 
 
EQ-5D = 0.57867 +0.0103667*PCS-12 + 0.00822*MCS-12 – (0.000034*PCS-12*MCS-12)-
0.01067. 
 
RESULTS 
Table 1 summarizes total costs across the three years of trial implementation for each study 
arm by program set-up and maintenance; program activities and overhead/miscellaneous day-to-
day costs. For the standard care arm, the total cost was $18,189.52 and per participant cost was 
$69.96. For the intervention arm, the total cost was $83,072.40 and per participant cost was 
$300.99. Salary for program activities represented the largest difference in costs, wherein 
intervention arm spent $51,671.36 more than the estimated cost of the standard care arm, largely 
concerning administrative staff and activities.  
 Table 2 depicts the study sample characteristics (see Coronado et al., 2016 for more detail). 
Nearly half of our sample was 42-49 years old, married, and employed at the point of baseline data 
collection. Nearly a third had a 4th grade education or less. The majority of the sample preferred 
Spanish, was born in Mexico, and lacked healthcare insurance. Most participants had not obtained 
a mammogram in their lifetime. 
Over the course of the trial, 54 of 276 women in the intervention arm (20%) and 29 of 260 
women in the standard care arm (11%) obtained mammograms. As shown in Table 3, the 
incremental cost per additional woman screened for this intervention was $2,595.32.  
We further estimated 1-year QALYs, with the sample of participants who completed the 
SF-12 survey during their 12-month follow-up (Table 3).  In terms of attrition, 100 participants 
did not follow-up and 16 had partial data for which the SF-12 could not be determined. Relative 
to the excluded participants, the 420 participants who completed the 12-month follow-up survey 
were more likely to be Mexican-born (83% vs 72%; p=.009) and less likely to be randomized to 
the intervention (74% vs 83% p = .02).  Other socio-demographic and breast cancer screening-
related variables were not significant (ps = 0.16-0.86).  Notably, we did not find study arm 
differences in QALY-related outcomes.
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Table 1. Costs in USD 2019 associated with intervention to motivate mammography use among non-adherent 
US-based Latinas and cost per individual Latina 
 Standard Care Intervention 
Expense category Total Cost  Per participant  Total Cost  
Per 
participant  
Program Set-up and 
Maintenance     
Initial training $1,542.00 $5.93 $3,437.37 $12.45 
Annual training $303.37 $1.17 $1,927.32 $6.98 
Training preparation $235.60 $0.91 $1,546.74 $5.60 
Program Implementation      
Intervention delivery activities $8,541.13 $32.85 $12,690.85 $45.98 
Administrative activities $7,234.29 $27.82 $54,755.93 $198.39 
Overhead/Miscellaneous Costs     
Travel $12.80 $0.05 $2,429.12 $8.80 
Cellphone $0.00 $0.00 $1,138.25 $4.12 
Office furnishings $298.07 $1.15 $5,007.30 $18.14 
Mailing $22.26 $0.09 $139.52 $0.51 
TOTAL $18,189.52 $69.96 $83,072.40 $300.99 
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Table 2. Study sample demographics adapted from Coronado et al., 2016 (n=536) 
  
Intervention 
  
Standard Care 
  
  N % n % 
Age         
 42-49 99 47% 169 52% 
 50-64 80 38% 126 39% 
 65-74  31 15% 31 10% 
Language         
  Spanish 189 90% 302 93% 
  English/Other 20 10% 24 7% 
Birthplace         
  Mexico 145 69% 288 88% 
  United States/Other 63 30% 39 12% 
Education         
  ≤4th grade 58 28% 98 30% 
  5-8th grade 57 27% 111 34% 
  ≥9th grade, no high school 26 12% 32 10% 
 ≥High school diploma/GED 65 31% 84 26% 
Marital status         
  Married or living with partner 109 52% 210 64% 
  Never married/widowed/divorced/separated 99 47% 116 36% 
Currently employed 108 51% 138 42% 
Health insurance status         
  Uninsured 148 70% 239 73% 
  Insured (Any) 60 29% 88 27% 
Previous mammogram (Ever) 27 13% 14 4% 
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Table 3. Cost-effectiveness analysis   
 Standard Care Intervention 
Primary Model (n =536)   
Number of women 260 276 
Number of women obtaining mammograms 29 54 
Difference between number of women screened across study arms -- 25 
Cost per woman $69.96 $300.99 
Cost per additional woman (intervention over control) -- $2,595.32 
Number of women completing 12 month follow-up 215 205 
Number of women completed 12 month follow-up who obtained 
mammograms 35 51 
Difference in number of women completed 12 month follow-up 
who obtained mammograms -- 16 
Quality of Life Adjusted Years (QALY)-related outcomes 
(n=420)1   
SF-12 Mental Health Component2 50.0229 50.3135 
SF-12 Physical Health Component2 50.1948 49.6818 
Mean QALYs (420 participants)3 0.8827 0.8841 
1Data available for 420 participants who completed SF-12 instruments at 12-month follow-up survey. 2 Short-Form Health 
Survey (SF-12).  3EQ-5D = 0.57867 +0.0103667*PCS-12 + 0.00822*MCS-12 – (0.000034*PCS-12*MCS-12)-0.01067. 
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DISCUSSION 
Advances in intervention science and health policy have made it possible to address a 
number of barriers that result in low adherence to mammography guideline among US-based 
Latinas. Our work adds to a growing body of cost-effectiveness research on CHW mammography 
screening interventions and public health practice implementation (Reeves, Edmunds, Searles, & 
Wiggers, 2019).  
Our intervention costs were within the range of other studies ($70-$500+; (Andersen et al., 
2002; Meghea & Williams, 2015; Stockdale et al., 2000; Viswanathan et al., 2010). Our 
incremental cost-effectiveness ratio also fits within the range of incremental cost-effectiveness 
ratios for other CHW interventions to promote mammography screening ($559-$4986 (Andersen 
et al., 2002; E. Paskett et al., 2006; Stockdale et al., 2000; Thompson et al., 2002). Administrative 
costs, associated with supervision, fidelity, and inter-agency coordination, were the largest 
expense. This pattern of costs parallel other economic evaluations of CHW interventions that have 
incorporated costs associated with staff from healthcare organizations and academic institutions 
(Andersen et al., 2002) versus other programs that have incorporated only costs associated with 
CHW and other staff from non-profit, faith and community based organizations (Meghea & 
Williams, 2015; Stockdale et al., 2000). Such costs may be important to incorporate when 
considering the delicate balance between fidelity of implementing evidence-based practices 
(Harris et al., 2012). Another strength of our study is that it provides data regarding the costs and 
cost-effectiveness of promotora-based approaches focusing on non-adherent populations and 
relying on rigorous study design. Our findings suggest CHW interventions may be comparable in 
costs and cost-effectiveness for promoting screening among underserved, non-adherent Latinas 
relative to other groups of women.  
This study had several limitations. First, our study did not use a societal perspective and 
did not rely on standardized metrics for economic evaluation. On the one hand, we offer 1-year 
QALY estimates that incorporate the effectiveness of mammography promotion, which is 
generally omitted from models that estimate the cost-effectiveness analysis. On the other hand, 
our 1-year time period unfortunately is not appropriate for calculating standardized metrics, which 
incorporate downstream costs and benefits across multiple episodes of screening and other breast 
cancer care. However, our 1-year QALY estimates offer some information regarding promotion, 
which is generally not incorporated in models that generate such standardized metrics. Future 
studies are warranted-- particularly those that are guided by these pilot data-- that employ a societal 
perspective and rely on standardized effect measurements to identify cost and effect drivers 
underlying program cost-effectiveness. Given the lack of differences in outcomes and moderate 
differences in costs, future modeling that incorporates a lifetime perspective may not necessarily 
find this type of mammography promotion to be cost-effective. Second, we had difficulties 
obtaining costs associated with standard care, which likely affected the precision of our cost 
estimates. Third, the parent study relied on non-probability based sampling. Specifically, our study 
was based on a clinical sample of participants who were largely Mexican, Spanish monolingual, 
uninsured, and less educated. Thus, our findings may not be applicable to populations who differ 
in country of origin, preferred language, educational attainment, insurance status, and access to 
healthcare systems (e.g., private healthcare systems, no healthcare access). Thus, our findings may 
not be generalizable. Further, our 1-year QALY estimates also indicate our studies may have 
limited generalizability, as shown by preliminary analyses among those who were lost to follow-
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up and those who completed the 12-month follow-up surveys. Fourth, these findings should also 
be considered in the context of debates and shifting guidelines regarding mammography screening, 
especially among the 40-49 year old population (Chetlen, Mack, & Chan, 2016; Swain, 2016). 
Unfortunately, our study could not disentangle the costs associated with mammography promotion 
for 42-49 year old participants and other participants in our study. Future studies are warranted, as 
the incremental cost effectiveness ratios for 40-49 year olds may not be as favorable compared to 
other age groups, wherein mammography may be more effective for increasing early stage 
detection and reducing breast cancer mortality. Relatedly, it is worth considering that incremental 
cost-effectiveness ratios that incorporate not only mammography promotion, but also costs 
associated with mammography and adverse consequences (e.g., false-positives, negative 
psychological consequences), may further have less favorable results than those reported in this 
pilot study. 
 
CONCLUSION 
 In conclusion, we found preliminary evidence to suggest that CHW interventions may not 
only be modestly effective but also comparably cost-effective relative to other underserved 
populations. Such research is timely in light of the importance placed on community-based care 
and lay health workers in the era of healthcare reforms and shifting healthcare context (Martinez, 
Ro, Villa, Powell, & Knickman, 2011). 
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